Calgary, AB – TheNewswire - April 13, 2023 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has processed a closing of $180,000 under its previously announced (see News Release of March 16, 2023) offering of convertible debt securities (the “Offering”).  The Offering consisted of “Secured [...]

Calgary, AB – TheNewswire - March 30, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it has reached an agreement (the “ Offer ”) to sell its 20-acre undeveloped island property located in Belize (the “ Property ”) for USD 1,300,000.  A summary of the terms of the sale [...]

Calgary, AB - TheNewswire - March 16, 2023 - Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that following preliminary approval by the TSX Venture Exchange (the “TSXV”), it has slightly modified the terms of its pending offering of convertible debt securities (the “ Offering ”, as was described in the Company’s prior [...]

Calgary, AB – TheNewswire - February 6, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering of convertible debt securities (the “ Offering ”).  The Offering consists of up to $5 million of “Secured Guarantee Convertible Notes” (the “ Notes ”) which [...]

Calgary, AB – TheNewswire - January 23, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it’s addiction and mental health treatment clinic, the Kelburn Recovery Center (“ Kelburn ”), which operates near Winnipeg, Manitoba via a wholly-owned subsidiary of UI, has re-opened effective January 23, 2023. Dr. [...]

Calgary, AB – TheNewswire - January 4, 2023 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, is pleased to provide a year end summary of 2022 accomplishments. Nick Karos, Chief Executive Officer and board member of [...]

Calgary, AB – TheNewswire - December 9, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, announces that it has agreed to issue 350,000 common shares (at a deemed price of $0.05) as part of a settlement agreement related to a claim filed in August 2021 by a [...]

Calgary, AB – December 1, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care, advises that it is in process of finalizing an offering (the “ Offering ”) of convertible debt securities.  The Offering will consist of “Secured Guarantee Convertible Notes” (the “ Notes ”) which will bear interest at [...]

Vancouver, BC / December 1, 2022 / Universal Ibogaine Inc. (the “Company”) (TSXV: IBO) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”) previously announced on October 3, 2022. (the “Debt Offering”) The Company has issued Notes in the aggregate principal amount of $626,500 CAD. The Notes shall mature 3 years from [...]